ACSS2 and neoplasm: To validate the critical role of ACSS2 in PDAC baseline tumours without CAFs, we assessed the growth of orthotopic tumours depleted for ACSS2 in the in vivo model without CAFs and let the tumours grow longer until the mice reached the euthanasia criteria (Extended Data Fig. 5l–o).